The QualityStocks Daily Tuesday, September 11th, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (AGRX) +116.83%

QualityStocks (ASCK) +49.50%

MarketClub Analysis (AOI) +36.47%

The QualityStocks Daily Stock List

American Rebel Holdings, Inc. (AREB)

Market Screener, Stockwatch, TradingView, Dividend Investor, Penny Stock Hub, Capital Cube, Wallmine, Investors Hangout, Stocks News Feed, Simply Wall St, Morningstar, 4-Traders, Barchart, OTC Markets, MarketWatch, Wallet Investor, and Street Insider reported on American Rebel Holdings, Inc. (AREB), and today we report on the Company, here at the QualityStocks Daily Newsletter.

American Rebel Holdings, Inc. engages in developing diverse products in the self-defense and patriotic product areas. The Company centers on designing, manufacturing, and marketing concealed carry backpacks under the American Rebel brand name. Mr. Charles A. "Andy" Ross founded the Company as America's Patriotic Brand. American Rebel Holdings has its corporate office in Nashville, Tennessee. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s initial product offering is its line of concealed carry products. These were launched at the 2017 NRA (National Rifle Association) Annual Meeting. The design of American Rebel’s products is to give one the tools needed to defend and protect oneself, their family and more. The Cartwright Concealed Carry Coat by American Rebel is featured in the third installment of a five-part series in the NRA Publication America's 1st Freedom on how to choose the right handgun to carry for defensive purposes.

American Rebel Holdings’ Chief Executive Officer, Mr. Andy Ross, said, "There's a growing need to know how to protect yourself, your family, your neighbors or even a room full of total strangers. That need is in the forethought of every product we design."

Recently, American Rebel announced it signed a supplier agreement with MidwayUSA. At present, a number of American Rebel concealed carry backpacks are available in the Midway online store. MidwayUSA is the nation's largest online retailer of guns, ammunition, and accessories.

In August, American Rebel Holdings announced that its Freedom Backpack line, available in four innovative designs, offers an optional add-on purchase of a Ballistic Panel Insert. The panel is soft armor. It fits into a custom sleeve in the Freedom Large Concealed Carry Backpack. The protection level of the panel is NIJ IIIA, which is good for everything up to and including .44 Magnum. American Rebel will shortly release the Student's PROtection Pack series.

American Rebel was awarded U.S. Patent No. 9,984,552 (the '552 Patent) on May 29, 2018. The '552 Patent encompasses the Company's unique Concealed Carry Backpacks, Luggage, Purses, Clothing, or other items one would carry. The new products work with American Rebel's forthcoming smartphone app to alert the user on the user's smartphone when they are entering a geo-fenced area.

American Rebel Holdings, Inc. (AREB), closed Tuesday's trading session at $1.05, down 8.70%, on 180 volume. The average volume for the last 60 days is 682 and the stock's 52-week low/high is $0.699/$2.50.

chart

Invictus MD Strategies Corp. (IVITF)

NetworkNewsWire, TipRanks, Penny Stock Tweets, Stockhouse, Market Screener, OTC Markets, Investing News, YCharts, Daily Marijuana Observer, CapitalCube, Barchart, Equities, The Street, Dividend Investor, Pot Network, Emerging Growth, Profit Confidential, Insider Financial, Financial Content, Midas Letter, InvestorsHub, Wallet Investor, MarketWatch, and GuruFocus reported on Invictus MD Strategies Corp. (IVITF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Invictus MD Strategies Corp. is an international cannabis company listed on the OTC Markets Group’s OTCQX. Invictus offers a selection of products under a broad range of lifestyle brands. The Company and its subsidiaries mainly engage in the investment, acquisition, and development of synergistic businesses in the medical cannabis industry in Canada. Invictus MD Strategies is headquartered in White Rock, British Columbia.

The Company’s dedication is to providing patients and adult users with high-quality medical-grade cannabis. It represents a strong platform of licensed cannabis producers throughout Canada. Invictus MD Strategies has secured one of the strongest cultivation profiles in Canada, supported by greater than 250 acres of production capacity.

Through concentrating on expanding its production capability, Invictus is forecast to produce greater than 50,000 kgs by 2021. The Company supports its growers with state-of-the-art production and processing facilities.

Invictus MD Strategies’ portfolio includes Acreage Pharms Ltd. (West-Central Alberta – 100 percent Ownership); AB Laboratories, Inc. (Hamilton, Ontario – 50 percent Ownership); and AB Ventures, Inc. (Hamilton, Ontario - 33.3 percent Ownership). The Company’s portfolio also includes Future Harvest (Kelowna, British Columbia - 82.5 percent Ownership).

At the end of August, Invictus MD Strategies announced the introduction of four lifestyle-inspired cannabis brands for recreational users to become available across the Company’s distribution network under the omnichannel Terra World. Invictus is curating a selection of brands, which mirror the different lifestyles of the recreational user. Invictus brings to market Dukes, Zooey, Sterling & Hunt, and Sinister. Each of these address a specific target audience and his or her lifestyle.

Invictus MD Strategies has completed its first shipment of recreational cannabis under Provincial supply agreement on schedule. This ensures quality product for opening day on October 17, 2018. To date, the Company’s wholly-owned subsidiary, Acreage Pharms, has secured provincial supply agreements for the imminent adult recreational markets in British Columbia and Alberta.

Today, Invictus announced that it entered into a non-arm's length arrangement agreement dated September 10, 2018, with Poda Technologies, Inc. to give effect to the spin-out transaction announced on August 21, 2018. The Agreement sets out the terms of the statutory plan of arrangement involving Invictus, its security holders, and Poda.

The Arrangement, if completed, will result in shareholders of Invictus as at the effective date of the Arrangement being entitled to receive, for each common share of Invictus held as at such date - one post-Arrangement common share of Invictus; and one common share of Poda. Poda engages in the development of a new and improved vaporization technology.

Invictus MD Strategies Corp. (IVITF), closed Tuesday's trading session at $1.41399, up 4.74%, on 328,744 volume. The average volume for the last 60 days is 195,475 and the stock's 52-week low/high is $0.893/$2.759.

chart

PetroShare Corp. (PRHR)

DreamTeamNetwork and SmallCapVoice reported earlier on PetroShare Corp. (PRHR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

PetroShare Corp. is a domestic oil and natural gas exploration and development company. It targets capital deployment opportunities in established unconventional resource plays. The Company formed to investigate, acquire, and develop oil and gas properties in the Rocky Mountain and mid-continent regions of the United States. PetroShare is headquartered in Englewood, Colorado and the Company lists on the OTCQB.

PetroShare’s present focus is in the Niobrara/Codell formations and adjacent oil and gas producing zones in the Rocky Mountain region. Specific targets are in the Wattenberg field within the DJ Basin of northeast Colorado.

The Company is expanding its group of properties by way of organic drilling and development, in addition to strategic acquisitions and joint ventures (JVs). Its properties include Todd Creek Farms (Southern Wattenberg Field, NE Colorado; Niobrara and Codell Oil and Gas Development).

PetroShare acquired an initial acreage position of roughly 1,280 gross acres (333 net acres) in the heart of the oil dominated Niobrara/Codell resource development fairway in the southern end of the Greater Wattenberg Field region of NE Colorado.

The Company’s properties also include the Buck Peak Prospect (Sand Wash Basin, NW Colorado; Niobrara Oil Development). This Prospect is 7,700 gross acres (1,000 net acres) located in Moffat County. PetroShare has drilled and completed two producing wells in this prospect. The Buck Peak Prospect targets oil and associated wet gas from the fractured Niobrara Shale formation. The Company’s Shook pad development program comprises 6 Codell wells and 8 Niobrara wells targeting all three Niobrara benches.

PetroShare announced in April of 2017 that its proved reserves as of December 31, 2016 (as prepared by Cawley, Gillespie & Associates, the Company's third-party reserve engineer), were approximately 6.3 million barrels of oil equivalent.

The estimated pre-tax value of future cash flows from its proved reserves, discounted at 10 percent (PV-10), was about $43 million, using commodity prices of $42.75 per barrel of oil (Bbl) and $2.48 per MMBtu of natural gas. The volume of the proved reserves is split 70 percent for oil and natural gas liquids (NGL) and 30 percent for natural gas.

Earlier this month, PetroShare provided an operations update. Mr. Fred Witsell, PetroShare President, said, "We have progressed on several fronts regarding the development of our asset base despite having limited capital at our disposal over the past couple of quarters. First, we have secured the rights-of-way required to begin pipeline construction and hook up on our Shook pad, and we are in discussions with service providers to have equipment on site by the middle of the first quarter 2018 to begin completion activities. We have also assembled six additional drill site spacing units (DSUs) with surface use agreements across our South Brighton assets and have approximately 100 permits approved, submitted or in process for operated horizontal wells in the area.”

PetroShare Corp. (PRHR), closed Tuesday's trading session at $1.36, up 0.74%, on 500 volume. The average volume for the last 60 days is 3,250 and the stock's 52-week low/high is $0.75/$1.70.

chart

SpendSmart Networks, Inc. (SSPC)

Marketbeat.com and Flagler Financial Group reported on SpendSmart Networks, Inc. (SSPC), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, SpendSmart Networks, Inc. does business as (d/b/a) SMS Masterminds (SMS). The Company provides proprietary loyalty systems and a collection of digital engagement and marketing services. These help local merchants build relationships with consumers and grow revenues. The Company formerly went by the name The SpendSmart Payments Company, Inc. It changed its name to SpendSmart Networks, Inc. in June 2014. SpendSmart Networks has its headquarters in San Luis Obispo, California.

At present, the Company delivers and manages loyalty platforms. These include merchant funded rewards; loyalty rewards tablet/kiosk, as well as proprietary rewards management systems. In addition, it delivers and manages mobile marketing technology. This includes text and email messaging, customer analytics and propensity marketing, patent pending automated engagement engine, and Text2Win sweepstakes features.

SpendSmart Networks is a specialist in Mobile. It assists local businesses in finding new customers, and turn existing customers into digital advocates. The Company will optimize a client’s website, produce more reviews, and get a client’s customers to return more frequently via SpendSmart’s loyalty and text message marketing strategies.

Furthermore, SpendSmart Networks delivers and manages enterprise level loyalty and mobile marketing consulting. This consists of monthly hands on reviews by its Certified Masterminds, campaign creation and optimization, and localized support.

The Company also provides mobile and loyalty marketing services for small and medium sized businesses. Additionally, it provides personalized Website, e-commerce, and mobile application (app) development services; and Web marketing tools and analytics.

Consumers' dollars go further when they spend it with merchants in the SpendSmart network of merchants. This is because they receive exclusive deals, earn rewards, and in due time build a connection with their favorite merchants.

SpendSmart Networks services are implemented and supported by an extensive network of certified digital marketing specialists (Certified Masterminds) who grow revenue and consumer relationships for merchants through loyalty programs, mobile marketing, and website development.

In October of 2017, SpendSmart Networks announced that it entered into a purchase agreement to sell its operational assets to Eclipse Marketing, LLC. The sale will permit the Company to decrease its ongoing monthly expenses and also improve its debt structure.

After this transaction, SpendSmart Networks’ intention is to find an existing private company to merge into its public entity.

Mr. Luke Wallace, SpendSmart Networks’ Chief Executive Officer, said in October, "This transaction provides the company with its best opportunity to clean its balance sheet and merge with a new company that has a strong potential for growth."

SpendSmart Networks, Inc. (SSPC), closed Tuesday's trading session at $0.0068, up 23.64%, on 333 volume. The average volume for the last 60 days is 2,943 and the stock's 52-week low/high is $0.00449/$0.028.

chart

Osprey Gold Development Ltd. (OSSPF)

Stockhouse, InvestorsHub, Morningstar, WatchDog Stocks, MarketWatch, 4-Traders, OTC Markets, Junior Mining Network, Investing News, and Stock Orange reported on Osprey Gold Development Ltd. (OSSPF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Osprey Gold Development Ltd. concentrates on exploring five historically producing gold properties in the Province of Nova Scotia. The Company’s flagship project is Goldenville, in the historical mining district Goldenville, which is one of eastern Canada’s most significant gold belts. Osprey Gold has the option to earn 100 percent (subject to certain royalties) in all five properties. This includes the Goldenville Gold Project. Osprey Gold Development is based in Vancouver, British Columbia.

The Goldenville Gold Project is in Guysborough County, Nova Scotia. It was the subject of the recently completed 3,044 meter (m) diamond drill program. This Project recorded more than 212,300 ounces of gold production between 1862 and 1942.

Goldenville has an updated NI 43-101 inferred resource, which includes 2,800,000 tonnes at 3.20 g/t gold for a total of 288,000 ounces of gold (2.8 mil tonnes at 4.96 g/t gold for 447,000 ounces of gold uncapped).

In addition, Osprey Gold is exploring the past producing Caribou, Lower Seal Harbour, Miller Lake, and Gold Lake gold projects. It entered into a definitive agreement whereby it has acquired an option to acquire the Caribou Gold Property from John Logan Enterprises Ltd. With this Option Agreement, Osprey Gold may acquire a 100 percent interest (subject to certain royalties) in 16 contiguous mining claims (256 hectares) hosting the past-producing Caribou Property. The Caribou Gold contains an historic gold deposit that was intermittently mined between 1869 and 1955.

The Lower Seal Harbour project is in Guysborough County, Nova Scotia. The property is approximately 35 kilometers from Goldenville. Gold at Lower Seal Harbour is found in the veins and the host rocks.

The Miller Lake Project is about 14 kilometers from Goldenville. It has historic production and limited recent exploration. The Gold Lake Project is roughly 70 kilometers northeast of Halifax. It was discovered in 1867 with minor production taking place in the late 1800’s.

Last month, Osprey Gold announced additional assay results from its 18 hole, 3,044 meter (m) drill program at its Goldenville Property. Of note in the 2017 holes are numerous significant intercepts reflecting the mineralized nature of the Goldenville trend where gold is hosted in an assortment of stacked quartz veins and host rocks within a large anticlinal fold.

Osprey Gold Development President, Mr. Cooper Quinn, said, "We're very happy with the results of this program. These results support the potential to expand our current resource at Goldenville. The drill program also tested for broader zones of mineralization outside of the vein-hosted gold; this was successful in the southern limb of the Goldenville anticline in hole G17-14 which contained multiple intercepts of lower grade mineralization within the host rock. In the northern limb, results in the Bluenose Mine shaft area are very encouraging, returning the highest grades Osprey has drilled to date as well as broad zones of mineralized host rock and quartz veining, highlighted in hole G17-15 drilled over 300 m along strike to the east from G17-14."

At the beginning of March, the Company announced assay results from three holes drilled on the western portion of the Goldenville property in the Mitchell Lake Zone. The release includes results for three holes totaling 435 m. All three holes hit numerous intervals of gold mineralization, characterized by high grade quartz vein hosted gold and broad lower grade gold intercepts with mineralized host rock and veinlets.

Osprey Gold Development Ltd. (OSSPF), closed Tuesday's trading session at $0.041, up 2.50%, on 50,200 volume. The average volume for the last 60 days is 28,492 and the stock's 52-week low/high is $0.029/$0.1679.

chart

Weyland Tech, Inc. (WEYL)

DreamTeamNetwork, Penny Stock Hub, Dividend Investor, Wall Street Mover, Stockwatch, Marketbeat, OTC Journal, Stockhouse, SeeThruEquity, Simply Wall St, and InvestorsHub reported earlier on Weyland Tech, Inc. (WEYL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Weyland Tech, Inc. is a provider of mobile business applications. The emphasis of its CreateApp platform is on the Asia markets. At present, Weyland Tech offers the CreateApp platform directly in Singapore, India (Jaipur), and the U.S. and Canada. Weyland Tech is based in Hong Kong and the Company lists on the OTC Markets Group’s OTCQX.

The "CreateApp" platform enables SMBs (Small-Medium-Sized Businesses) to create a mobile application without the requirement of technical knowledge and background. Weyland Tech’s CreateApp platform is provided in 14 languages.

Currently, the Company offers a DIY (Do-it-Yourself) App builder by way of a 'white label' platform. It offers this via strategic partnerships in the EU (minus Russia, Turkey, Armenia, Azerbaijan); Malaysia; Hong Kong/South China; Indonesia; and North/Central/South America. It will offer this in Korea through IAM, Inc.

This past May, Weyland Tech expanded its portfolio to FinTech applications with the launch of its AtoZPay mobile payments platform. The mobile wallet launched in the world’s 4th most populous country, Indonesia. It is experiencing quick growth in transactions occurring on the platform.

AtoZPay’s Gross Transaction Value (GTV) grew to over a $7 Million run-rate up from the $5.0 Million realized in the first week of May. The Company believes it is on its way to the $25-35 million in GTV run-rate targeted for year end. When combined with its 2019 targets of $80 Million GTV, Weyland Tech anticipates meeting or surpassing its target of roughly $100 Million in GTV within 18-months of launch.

Recently, Weyland Tech updated shareholders on its Q2 results and eWallet business. Service Revenue increased 36 percent year over year reaching $8,838,686 from $6,476,022 for the six months ended June 30, 2018 and 2017, respectively.

Weyland Tech recently announced a strategic partnership between its eWallet business and PT. Finnet Indonesia. Its eWallet business, AtoZPay, and Finnet entered into a strategic partnership. Under the terms of the relationship consumers can ‘top-up’ their mobile phones at Alfamart. This is the largest convenience store chain in Indonesia, with 13,477 locations. Longer term, AtoZPay users will be able to make bill payments on household and business utilities on Finnet’s network of approximately 80,000 ATM machines within Indonesia.

Last week, Weyland Tech announced that its eWallet business, AtoZPay, entered into numerous additional agreements with companies in Indonesia. This is to enable users of AtoZPay to pay for goods and services from these companies.

Weyland Tech, Inc. (WEYL), closed Tuesday's trading session at $3.29, up 20.07%, on 307,664 volume. The average volume for the last 60 days is 43,117 and the stock's 52-week low/high is $0.962/$7.079.

chart

IDM Mining Ltd. (IDMMF)

Stockhouse, InvestorsHub, and MarketWatch reported on IDM Mining Ltd. (IDMMF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

IDM Mining Ltd. is a mineral exploration and development company listed on the OTC Markets Group’s OTCQB. The Company focuses on low capital expenditure, high-grade precious metal asset development. Its present exploration and development activities center on precious metals in British Columbia (BC). The Company’s principal emphasis is on the high-grade, underground Red Mountain Gold Project. IDM Mining has its corporate headquarters in Vancouver, British Columbia.

The Red Mountain Gold Project is 15 kilometers east of Stewart, BC, and is 17,125 hectares. It is advancing through the BC and Canadian environmental assessment processes with complete, thorough, and continuing consultation with Nisga'a Nation.

Red Mountain has premier exploration potential for additional discoveries along a 12-kilometer trend of numerous prospects and favorable geology.

Red Mountain hosts a well-drilled, high-grade resource, accessed by a production-sized underground decline. The deposit (at an average potential mining width of 16 meters) is amenable to low-cost bulk mining techniques such as longhole stoping.

The Company is advancing a Feasibility Study (FS) for a high-grade, underground gold mine. It envisions primarily bulk underground mining methods and the production of gold doré on site.

In February, IDM Mining announced significant and encouraging progress from the geologic compilation of drill results from the 2017 exploration program at the Red Mountain Gold Project. The work is now progressing towards an updated resource estimate in spring of this year. It will incorporate the revised geological model, 2017 drilling results, as well as historic gold intercepts, which were not earlier included in the present resource estimate.

Mr. Robert McLeod, IDM Mining’s President and Chief Executive Officer, said “Our new interpretation, which has identified significant near-mine resource potential, represents an important turning point for the Company. The recognition of high-amplitude, post-mineralization repeating folds has opened up multiple areas to resource expansion that were previously thought closed off or having lower exploration potential.”

In addition, in February, IDM Mining announced an expanded marketing team, with the appointment of Ms. Vanessa Pickering as Manager of Corporate Communications and Development. In this role, Ms. Pickering will work closely with the Board of Directors and Management of IDM Mining to implement progressive communications and marketing/outreach programs, which align stakeholders with the exploration and potential development of the Red Mountain Underground Gold Project. In addition, IDM Mining has retained Mr. Ryan Pownall as Junior Investor Relations Coordinator.

IDM Mining Ltd. (IDMMF), closed Tuesday's trading session at $0.0559, up 11.80%, on 40,000 volume. The average volume for the last 60 days is 31,629 and the stock's 52-week low/high is $0.043/$0.1209.

chart

TechCare Corp. (TECR)

InvestorsHub, Barchart, Stockhouse, OTC Markets, Investing, 4-Traders, GuruFocus, PennyStockTweets, Investors Hangout, and Emerging Growth reported on TechCare Corp. (TECR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

TechCare Corp. has a unique delivery platform, which uses vapor technology for natural health and beauty treatments. The Company engages in the design, development, and commercialization of this inventive delivery platform using vaporization of different natural, plant-based compounds, to enable a broad array of treatment solutions. A technology enterprise, TechCare is headquartered in New York, New York. The Company lists on the OTC Markets Group’s OTCQB.

TechCare has a strategic partnership agreement with HoMedics, one of the world's foremost brands in health and wellness products. HoMedics will manufacture, market, and distribute TechCare's Novokid products in the U.S., Canada, Brazil, Argentina, Colombia, and Costa Rica. The products will be co-branded as HoMedics products powered by TechCare.

Novokid consists of a portable device that vaporizes TechCare's all-natural, plant-based solution contained in a disposable capsule. It comes with a proprietary head cap. Novokid is the first of its kind home use device. It presents a scientifically proven solution to eliminate lice, super lice, and eggs.

Novokid is 100 percent natural, plant-based and pesticide-free. Novokid utilizes a proprietary vapor-based delivery platform. TechCare’s Novokid has received CE Mark approval as a CLASS I Medical Device. Novokid uses a simple 10-minute dry treatment. The treatment requires no rinsing or washing and is quick, dry, and clean. It is easily administered at home or while mobile. Moreover, Novokid can be used as a maintenance and preventative treatment if used regularly.

At the end of May 2018, TechCare announced that following intensive R&D and investments, it expanded its existing IP portfolio with a recently submitted patent application of its Smart Capsule™ technology. Building upon its existing patents and knowledge, the new Smart Capsule™ technology enables the vaporization of two or more compounds at the same time. Therefore, this expands the range of applications while yielding superior performance, usability and ease-of-use.

TechCare Corp. (TECR), closed Tuesday's trading session at $0.25, up 25.00%, on 2,033 volume. The average volume for the last 60 days is 3,711 and the stock's 52-week low/high is $0.019/$0.75.

chart

TechPrecision Corp. (TPCS)

Energy and Capital, Wealth Daily, TopPennyStockMovers, Zacks, Stock Rich, FeedBlitz, SmallCapVoice, BullRally, HotOTC, CoolPennyStocks, PennyStockVille, MadPennyStocks, Marketbeat, StreetInsider, and Stock Market News Alert reported earlier on TechPrecision Corp. (TPCS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

TechPrecision Corp., through its wholly-owned subsidiaries, Wuxi Critical Mechanical Components Co., Ltd., and Ranor, Inc., is an industry leading manufacturer of precision, large-scale fabricated and machined metal components and tested systems. The Company’s objective is to be an end-to-end global service provider to its customers through furnishing customized and integrated turn-key solutions for completed products requiring custom fabrication and machining, assembly, inspection, and testing. OTCQB-listed, TechPrecision has its headquarters in Westminster, Massachusetts.

The Company’s products are used in the alternative energy, medical, nuclear, defense, and precision industrial, aerospace, and naval/maritime markets, among others. TechPrecision has the fabrication capacity to see a client’s large-scale components through from initial processing to final finishing and assembly. This eliminates the requirement for outside servicing. In addition, it helps ensure lower costs.

TechPrecision’s Ranor subsidiary specializes in large-scale, precision component fabrication for the Clean Technology, Energy, Medical, Aerospace, and Defense sectors. Ranor’s capabilities include Production Control; Engineering; Processing; Fabrication; Machining; Assembly & Finishing; Quality Assurance, and NDE & Inspection.

The design of the Wuxi Critical Mechanical Components (CMC) subsidiary is to meet the growing worldwide demand for an experienced, knowledgeable machining and distribution center in Asia, providing large-scale component fabrication solutions for the region's wind power and solar challenges. CMC utilizes one of the largest forges in the industry.

CMC’s capabilities include Forging; Fabrication; Machining; Inspection; Assembly & Finishing, and Quality Assurance. CMC serves the Solar/LED; Wind; Nuclear; Clean Technology, Medical; and General Industrial industries.

Recently, TechPrecision reported financial results for Q1 ended June 30, 2018. Net Sales for Q1 were $4.1 million. This represents a 30 percent decrease versus Net sales of $5.8 million in the same quarter a year prior. The Q1 June 30, 2017 Net Sales were higher due to favorable timing with delivery schedules in that year ago period.

Mr. Alexander Shen, TechPrecision's Chief Executive Officer, said, ''Our results for the first quarter were impacted by lower gross margins, which were primarily the result of higher amounts of unabsorbed overhead related to a lower number of projects in production. By the end of the first quarter, however, we have started to return to target levels of project activity, primarily with certain projects that have longer build cycles.''

TechPrecision Corp. (TPCS), closed Tuesday's trading session at $0.765, even for the day, on 9,000 volume. The average volume for the last 60 days is 35,573 and the stock's 52-week low/high is $0.4602/$0.7799.

chart

Medifocus, Inc. (MDFZF)

Investor Network, Barchart, Street Insider, FinancialContent, TradingView, MoneyHub, OTC Markets, MarketWatch, and Wallet Investor reported earlier on Medifocus, Inc. (MDFZF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Medifocus, Inc. has a portfolio of medical technologies, which use patented Focal Thermal Technology to treat conditions ranging from Prostate Diseases to Breast Cancer. The Company’s portfolio of medical products includes thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and breast cancer. OTCQB-listed, Medifocus is based in Columbia, Maryland.

The Company owns two technology platforms with approximately 100 issued and pending U.S. and international patents. One platform is the “Endo-thermotherapy Platform”. The other platform is the “Adaptive Phased Array Microwave Focusing Platform”. Based on these proprietary technology platforms, Medifocus has developed two advanced therapeutic products. One is the Prolieve® system for the treatment of BPH. The other is the Adaptive Phased Array (APA)-1000 system for the treatment of breast cancer.

The Prolieve® Thermodilatation™ System provides symptomatic relief to men with Benign Prostatic Hyperplasia (BPH) via a simple, 45-minute, in-office treatment. Prolieve® is Food and Drug Administration (FDA) and Medicare approved for treating symptomatic BPH with more than 100,000 cases performed in the U.S. alone, and with proven long-term safety, efficacy, and durability. The purpose of the Prolieve system is to provide a relatively painless and effective alternative to drug therapy, and also certain types of surgical procedures to treat the symptoms of BPH.

Medifocus’ Heat Activated Gene Therapy, exclusively licensed from Duke University, aims at using the Company’s Focal Thermal Technology to enhance selective expression of therapeutic genes injected intratumorally to optimize cancer cell killing while lessening systemic side effects.

The APA 1000 Breast Cancer Treatment System developed by the Massachusetts Institute of Technology (MIT) has been shown in Phase 2 clinical trials to offer substantial additional shrinkage of the sizes of breast cancer in combined ChemoThermal therapy versus Chemotherapy alone. In addition, it was shown to be effective in reducing margin positivity when patients were treated with APA 1000 before lumpectomy.

Medifocus announced this past June that the FDA completed the review of the Company’s rigorous FDA mandated Post Approval Study (PAS). The 5-year follow-up study satisfactorily fulfilled the PAS requirements. The PAS was conducted on a group of 225 symptomatic BPH patients treated with the Prolieve® Thermodilatation™ System.

Dr. William Jow, Medifocus President and Chief Executive Officer stated in June, "The successful completion of this PAS is a significant milestone and achievement for Medifocus. As a practicing urologist, I am glad that the PAS has demonstrated both excellent short-term and long-term clinical benefits. I am even more excited that the study has demonstrated stabilization of serum Prostate-Specific Antigen (PSA) level and prostate size during the 5-year follow-up period. These findings clearly indicate that Prolieve® TUTD™ has proven itself as a safe and effective clinical tool to provide relief of BPH symptoms, improve quality of life and stabilize PSA and prostate size."

Medifocus, Inc. (MDFZF), closed Tuesday's trading session at $0.022, even for the day. The average volume for the last 60 days is 1,750 and the stock's 52-week low/high is $0.012/$0.05139.

chart

Zynex, Inc. (ZYXI)

Zacks, FeedBlitz, SmallCapVoice, Daily Markets, SmarTrend Newsletters, BUYINS.NET, FNNO Newsletters, and TaglichBrothers reported earlier on Zynex, Inc. (ZYXI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Zynex, Inc. is a medical technology company listed on the OTC Markets Group’s OTCQB. It specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. In addition, it is developing a new blood volume monitor (non-invasive Blood Volume Monitor, CM-1500) for use in hospitals and surgery centers. Zynex has its corporate office in Englewood, Colorado.

The Company’s product lines are completely developed, Food and Drug Administration (FDA)-cleared, and commercially sold worldwide. Zynex engineers, manufactures, markets, and sells its own design of medical devices in three subsidiaries. Zynex believes that its non-invasive Blood Volume Monitor, CM-1500, will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery.

Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals. Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets. Zynex Medical is a provider of electrotherapy products for home use.

Zynex markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation. Additionally, it markets and sells its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. The design of the NeuroMove™ device is to assist stroke survivors in regaining movement using the brain's ability to rewire itself, also known as "neuro-plasticity".

New products in the Company’s portfolio include JetStream Hot/Cold Therapy, Aspen LSO Backbracing and Comfortrac cervical traction. All of these products are aimed at treating acute and chronic pain without side-effects.

Recently, Zynex reported financial results for its Q2 ended June 30, 2018.

Mr. Thomas Sandgaard, Chief Executive Officer, said: "I am pleased to report revenue of $7.6 million in the second quarter with net income of $2.4 million or $0.07 per diluted share. Adjusted EBITDA was $2.8 million and the quarterly revenue was 50% higher than the revenue of the second quarter of 2017. Revenue was up 10% from the $6.9 million recorded in the first quarter of 2018. Orders grew 29% compared to the second quarter 2017 and were 2% higher than the first quarter of 2018. Our cash on hand grew to $6.3 million at the end of the second quarter.”

Zynex, Inc. (ZYXI), closed Tuesday's trading session at $3.30, down 1.49%, on 11,896 volume. The average volume for the last 60 days is 33,782 and the stock's 52-week low/high is $1.10/$5.50.

chart

Freedom Leaf, Inc. (FRLF)

SmallCapVoice, Promotion Stock Secrets, CFN Media Group, and StocksToBuyNow reported on Freedom Leaf, Inc. (FRLF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Freedom Leaf, Inc. (The Marijuana Legalization Company™) is a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industry. The Company engages in mergers and acquisitions (M&A’s) in the marijuana industry. This includes incubation/acceleration and spin offs of new marijuana/hemp related companies. Freedom Leaf does not handle, grow, sell, or disperse marijuana. Freedom Leaf is headquartered in Las Vegas, Nevada. Leafceuticals, Inc. is a wholly-owned division of Freedom Leaf.

The Company targets acquisitions of high growth and niche companies. Its strategy is to identify select technology companies and companies that are involved in cannabis and industrial hemp genetics, intellectual property (IP), bioscience, nutraceutical, and pharmaceutical product development.

Freedom Leaf earlier acquired LaMarihuana.com. This is the Spanish Speaking community's top cannabis website. As part of this acquisition, Freedom Leaf acquired www.Marihuana-Medicinal.com. This is the largest Medical Cannabis information website in Spanish.

Freedom Leaf’s flagship publication is Freedom Leaf Magazine, The Good News in Marijuana Reform. Freedom Leaf produces a portfolio of news, print, and digital multi-media verticals, websites, and web advertising, for the ever-changing and developing cannabis, medical marijuana, as well as industrial hemp industry.

The content Freedom Leaf produces and curates primarily attracts industry professionals. This includes lawyers, legislators, activists, entrepreneurs, and people active in the business of cannabis and industrial hemp. The Freedom Leaf enterprise has become a leader in media production and distribution for the cannabis/hemp industry.

Hempology® is Freedom Leaf’s exclusively branded product line. Hempology® is now vertically integrated from seed to consumer, processing CBD and a comprehensive spectrum of whole-hemp extracts for the entourage-effect.

Freedom Leaf reported in August of 2017 significant developments in its Spanish acquisition, Green Market Europe (GME), in combination with University Miguel Hernandez in Elche, Spain. Freedom Leaf and GME signed a Letter of Intent (LOI) for Freedom Leaf to acquire 100 percent of GME's IP, projects, and assets.

Freedom Leaf agreed to expand two additional growing operations globally before the end of 2019 to maximize the skills and the potential of staff.

Last month, Freedom Leaf announced that it entered into a purchase agreement for organically grown hemp, which will permit it to legally extract Industrial Hemp in Nevada under NV SB396 and the 2014 US Farm Bill.

Leafceuticals, the wholly-owned division of Freedom Leaf, entered into an initial purchase agreement with hemp producer Harris Farms, Ltd, of Pahrump, Nevada to fully extract the wide array of phytocannabinoids (CBD), terpenes and other valuable byproducts from 600 pounds of nurtured Hemp flower that has been grown under the NV Department of Agricultures Industrial Hemp Pilot project.

Earlier in January, Freedom Leaf report that it fully acquired 100 percent of Green Market Europe S.L. (GME). GME is a Spanish producer of hemp products. Its facilities include a 21,000 sq. ft. light deprivation greenhouse, a 43,000 sq. ft. indoor growing research facility, and more than 200 acres of outdoor production space.

Freedom Leaf, Inc. (FRLF), closed Tuesday's trading session at $0.17575, up 1.88%, on 511,827 volume. The average volume for the last 60 days is 583,035 and the stock's 52-week low/high is $0.02649/$0.471875.

chart

Agritek Holdings, Inc. (AGTK)

CFN Media Group, Promotion Stock Secrets, PennyPro, SmallCapVoice, and Cannabis Financial Network News reported on Agritek Holdings, Inc. (AGTK), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Agritek Holdings, Inc. is a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis sector. It provides unique technology and agricultural solutions for the medicinal and recreational cannabis industry. Agritek Holdings is headquartered in Miami, Florida. The Company has a satellite office in San Juan, Puerto Rico.

Agritek Holdings does not directly grow, harvest, or distribute or sell cannabis or any substances that violate or contravene U.S. law or the Controlled Substances Act. It does not intend to do so in the future.

The Company owns property in Colorado approved for cultivation, and manufacturing capabilities by way of California partnerships. Also, it owns a number of Hemp and cannabis brands for distribution.

Agritek’s solution is an integrated platform designed for commercialization in three high-value segments of the global cannabis market – Real Estate, AGTK Brands/IP, and Infrastructure. The Company’s brands are a premium positioned set of consumer brands for medical wellness and recreational use. Agritek owns several hemp and cannabis brands for distribution. These include MD Vapes, MicroDose Strips, and "Hemp Pops" and "California Premiums.

The Company’s Colorado property is 80-Acres approved for cannabis cultivation or manufacturing facility in Pueblo, Colorado. Its Puerto Rico property is a 25,000-sq. ft. licensed cannabis cultivation and manufacturing facility.

Agritek’s Canada property is a cannabis friendly "Bud & Breakfast" concept. It is one hour from Quebec City, Quebec. It is on 15-acres that includes nine guest rooms plus a separate detached grow facility.

Regarding Agritek’s new state-of-the-art, San Juan-based facility, it contains 15,000 usable square feet that will be the first vertically integrated cannabis operation in San Juan, Puerto Rico that will operate as a cultivation and manufacturing facility, and also a separate space that can be dedicated to a retail dispensary partner.

Last month, Agritek Holdings announced that it ended its quarter with the first revenues from Hemp CBD sales via its California operations. B. Michael Friedman, Agritek Holdings’ Chief Executive Officer, stated, " We are beginning to see first revenue streams from our new brands focused within the Hemp and CBD markets in Colorado and California. Our unique product lines for the Hemp CBD market place within California and Colorado include our MD Oral Strips, MD Vape lines with multiple flavored terpenes, and our new Hemp Pops, which contain a 25 mg dose within a lollipop in six flavors.”

Furthermore, in February, Agritek Holdings announced that it has expanded manufacturing of the exclusive licensed “California Premiums” pre-roll brand to a licensed Pre-ICO manufacturing facility in Los Angeles, California. This new manufacturing facility will permit Agritek to straight away boost production of the California Premiums Brand to meet demand and requests by local dispensaries in West Hollywood and delivery services for the product.

Last week, Agritek Holdings announced that it received its first purchase order for 10,000 MD Vape cartridges from a licensed California based facility. Agritek will be the exclusive provider for cartridges and provide filling machines for the new private labeled line to be sold exclusively within the California recreational market. Agritek Holdings will receive royalties on the private labeled brand via its MD Vapes division separate and apart from the cartridge, vaporizer batteries, and filling machine purchase orders.

Agritek Holdings, Inc. (AGTK), closed Tuesday's trading session at $0.0107, up 1.90%, on 2,554,485 volume. The average volume for the last 60 days is 3,095,614 and the stock's 52-week low/high is $0.0086/$0.05449.

chart

The QualityStocks Company Corner

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Biotechnology company Earth Science Tech (OTC: ETST) is currently lab testing three new cannabidiol formulations, developing two more CBD products and conducting studies on its Hygee device for women. To view the full article, visit: http://nnw.fm/xx21J.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.76015, up 12.95%, on 25,879 volume. The average volume for the last 60 days is 12,229 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

chart

CytoDyn Inc. (CYDY)

The QualityStocks Daily Newsletter would like to spotlight CytoDyn Inc. (CYDY).

CytoDyn Inc. (OTC.QB: CYDY) announces that management will host an investment community conference call to provide a business update. A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 60 days. Web participants are encouraged to go to the website 15 minutes prior to the start of the call to register, download and install any necessary software. The webcast can also be accessed via the following link: Webcast. Also today, NetworkNewsWire released a report detailing the significant advantages of PRO 140, CYDY’s viral-entry inhibitor, over drugs currently used in HIV treatment therapies have been reported, namely showing little if any toxicity or side-effects in treated patients to date, ease of administration (once weekly dosing) and a lack of HIV resistance developing to the treatment.

CytoDyn Inc. (CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.

PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.

CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.

HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.

PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.

The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.

PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.

As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.

In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.

The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.

CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.

CytoDyn Inc. (CYDY), closed the day's trading session at $0.658, up 16.46%, on 354,212 volume. The average volume for the last 60 days is 348,437 and the stock's 52-week low/high is $0.40/$0.836.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (KBEVF).

Koios Beverage Corp. (CSE:KBEV)(OTC: KBEVF) (the "Company" or "Koios") is pleased to announce it will begin production of a new line of functional beverages under the brand 'Fit Soda', beginning in Q1 of 2019.

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (KBEVF), closed the day's trading session at $0.3503, up 16.22%, on 983,217 volume. The average volume for the last 60 days is 305,528 and the stock's 52-week low/high is $0.001/$0.5121.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) yesterday announced that it will present live at VirtualInvestorConferences.com on September 12, 2018, at 2:30 PM ET. Per the update, the conference will be a live, interactive online event that invites investors to ask the company questions in real-time – both in the presentation hall and at the association’s “virtual trade booth.” Those interested in participating are encouraged to pre-register and run the online system check at http://cnw.fm/5aZtv. To view the full press release, visit: http://cnw.fm/ASO3l.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $5.8615, up 7.96%, on 1,784,658 volume. The average volume for the last 60 days is 397,979 and the stock's 52-week low/high is $2.784/$7.565.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Payment processing technology company Net Element, Inc. (NASDAQ: NETE) is seeing rising revenues from its North American market and is weighing options for monetizing mobile operations on a global scale through its agent contracts, while additional value-added efforts have branded it a company that continues to identify growth initiatives with independent equity research firm SeeThruEquity (http://nnw.fm/jmMJ1).

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $5.93, up 3.67%, on 35,202 volume. The average volume for the last 60 days is 119,979 and the stock's 52-week low/high is $2.5559/$33.509.

Recent News

chart

NUGL Inc. (NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC: NUGL) (the “Company”), the cannabis industry's new standard of technology, today announces the expansion of its global marketing campaign to include a highly sought-after category - cannabis brands and accessories, which is estimated to be a $9 billion market and growing.

NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.23, up 0.82%, on 128,819 volume. The average volume for the last 60 days is 126,277 and the stock's 52-week low/high is $0.4/$1.799.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Cannabis companies are seeing substantial growth, with the popularity of cannabidiol (CBD) playing a significant part in their positive outlook. Youngevity International, Inc. (NASDAQ: YGYI) is one of these companies, having recently expanded its range of products to include CBD therapies for muscle pain, sleeplessness and mood improvement.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $3.72, up 3.33%, on 16,174 volume. The average volume for the last 60 days is 18,040 and the stock's 52-week low/high is $3.16739/$6.75.

Recent News

chart

The Flowr Corporation

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation.

The Flowr Corp., a vertically-integrated Canadian licensed producer that focuses primarily on premium flower production, was recently highlighted in an article discussing noteworthy players in the cannabis industry on Benzinga.com titled, “Pot Stocks, ETFs, Top News And Data From The Cannabis Industry This Week” authored by Javier Hasse. To view the full article, visit http://ibn.fm/6pXZb.

The Flowr Corporation, a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

Recent News

Cyberfort Software, Inc. (CYBF)

The QualityStocks Daily Newsletter would like to spotlight Cyberfort Software, Inc. (OTC: CYBF).

Cybersecurity technology company Cyberfort Software, Inc. (OTC: CYBF) recently announced the signing of a letter of intent for the acquisition of Just Content Software. The announcement came in mid-August 2018, and a final acquisition determination is anticipated in a few weeks (http://nnw.fm/v9Nbm). Also today, NetworkNewsWire released a report on the company detailing how this San Francisco, California-based cybersecurity outfit is truly “One to Watch.” To view the full article, visit: http://nnw.fm/3lQh8.

Cyberfort Software, Inc. (CYBF) is a cybersecurity technology company specializing in the acquisition and development of security software, content filtering, and ad blocking technology. Headquartered in San Francisco, California, Cyberfort Software is actively dealing with various cyber threats through the development of innovative protection technologies designed for mobile, personal and business tech devices across multiple platforms.

Committed to the idea that everyone – from individuals to global corporations – should be able to enjoy a digital future free of malicious attacks robbing them of privacy and security, Cyberfort is working to strengthen its portfolio of cybersecurity IPs and stay one step ahead of cyberthreats. The growing plethora of tech devices enveloping everyday life opens the door to increasing cyberattacks through a stunning array of sophisticated cyberthreats. Protecting organizations and individuals with proactive security postures and protective measures is a key component of Cyberfort’s strategy to develop cybersecurity solutions that are smart, simple and efficient.

The company’s 2016 purchase of Vivio, a provider of pioneering AI content filtering and software protection, underscores Cyberfort’s commitment to cybersecurity. Vivio, an iOS 10 ad blocking app, currently serves over 10,000 unique users across iPhone, iPad and Mac. Vivio makes web browsing better, faster and more satisfying by blocking ads and reducing data usage, which also helps save battery life. Continuous ad blocking rule updates are delivered via an Intellectual Property Cloud-based autonomous engine with ad blocking tracker and malware detection filters.

Cyberfort recently signed a letter of intent to acquire Just Content Software which includes the Just Content app, software and underlying source code. Just Content is an efficacious and multi-functional ad blocking app that safeguards families and businesses with proprietary “Home Safe Filter” and “Business Filter” products. The Just Content app is available on iTunes and protects against unsafe links, adult content, phishing sites and inflammatory hate speech found on the internet, among other potential backdoor attacks and cyberthreats. A due diligence review is underway and a final determination regarding this acquisition is anticipated within weeks.

“Cyberfort aims to become a leader in developing cutting edge ad-blocking protective software that keeps the internet safe for families and business, which in our highly technological and immediate information-access society is a significant concern. Acquiring Just Content furthers our commitment to provide the best and most effective ad-blocking software in the marketplace,” says Cyberfort CEO Daniel Cattlin.

Favorable government regulations promoting tightened web security is a major factor driving adoption of web content filtering solution along with the public’s growing desire to better manage network bandwidth consumption and protect their online security and privacy. Cyberfort’s objective is to protect the data and integrity of personal and business computing assets and defend those assets against any threat or attack. The company’s software also offers symbiotic ad-blocking capabilities to complement its cyber defense effectiveness.

As Cyberfort continues to innovate, the Vivio team intends to leverage the current user base as a sandbox to test and optimize future incremental developments targeting an enterprise suite of tools that can be integrated into sector specific areas of growth. Key areas of focus include mobile device management, bring your own device (“BYOD”), mobile app management and secure mobile browser.

The Cyberfort leadership team is headlined by Cattlin, who offers a new age perspective to the business with expertise in project and asset management and a background in corporate finance. Cattlin brings both the operational and financial understanding to take companies from start-up and early development to expansion and capital growth within a public environment.

Chief Technology Officer Tomas Mistrik helped his team deliver a variety of technological products including the Vivio ad-blocking app for iOS 10 and the Silicon Valley-based Synergykit platform for mobile developers.

Technology Development Manager Krishna Kumar brings more than 10 years of experience in the Information Technology industry where he provided powerful security and ad-blocking measures for companies such as CSC and PayPal India.

Senior Advisor Harish Doddala brings nine years of product management and software engineering experience, delivering results for Cisco, VMware, Oracle, IBM and Siemens.

Cyberfort Software, Inc. (OTC: CYBF), closed the day's trading session at $0.09, even for the day, on 9,000 volume. The average volume for the last 60 days is 35,213 and the stock's 52-week low/high is $0.0509/$69.00.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB:SING) announces the launch of LastMile Delivery. The platform aims to provide SMBs the ability to streamline their deliveries and give customers the insight and predictability of when a delivery will arrive.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0298, off by 1.32%, on 5,017,178 volume. The average volume for the last 60 days is 4,199,170 and the stock's 52-week low/high is $0.02349/$0.133.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV:PQE; OTC:PQEFF; FSE: PQCF), a fully integrated oil and gas company, announces that it has agreed to complete shares for debt transactions, pursuant to which it will issue an aggregate of 426,429 common shares in satisfaction of $480,670 of indebtedness currently owed to two arm’s length lenders and two arm’s length service providers.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $1.06, up 4.95%, on 467,466 volume. The average volume for the last 60 days is 389,854 and the stock's 52-week low/high is $0.289/$1.8891.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences industry, has added another patent to its intellectual property portfolio, bringing the total to 21 patents. Issued as U.S. Patent 9995661 and titled “Flow-through High Hydrostatic Pressure Microfluidic Sample Preparation Device and Related Methods Therefor,” this new patent is a significant development in the company’s strategic plan to develop automated “hands-free” sample handling for the next generation of PBI’s high-pressure sample preparation platform systems, a news release states (http://nnw.fm/1gOh3).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.50, off by 12.50%, on 3,136 volume. The average volume for the last 60 days is 1,771 and the stock's 52-week low/high is $2.70/$5.00.

Recent News

chart

Marifil Mines Ltd. (TSX.V: MFM) (OTC: MFMLF)

The QualityStocks Daily Newsletter would like to spotlight Marifil Mines Ltd. (MFMLF).

Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) today announced that it has received preliminary assay results for its diamond core drilling program at its San Roque property. The drilling program detailed in today’s update included four HQ-size core holes drilled for a total of 846 meters. To view the full press release, visit: http://nnw.fm/38FbB. Also today, NetworkNewsWire released a report on the company detailing junior Canadian explorer MFMLF’s lithium interests in Catamarca province, the same geologic and mining region that hosts FMC’s world-renowned Hombre Muerto mine.

Marifil Mines Ltd. (TSX.V: MFM) (OTC: MFMLF), headquartered in Vancouver, Canada, is engaged in the exploration, evaluation and acquisition of mineral rich resource properties in Argentina. A rising global demand for cobalt and lithium is generating interest in Marifil Mines and its resources located within South America’s famed “Lithium Triangle,” which include 15,267 hectares spanning its recently acquired Ratones and Fraile claims, as well as two lithium properties covering the southern portions of the Carachi Pampa salar in the Argentine province of Catamarca.

The company’s property also includes the Las Aguilas nickel-copper-cobalt deposit property, with more than four contiguous claims in the San Luis province of Argentina. The Las Aguilas property, which is 100% owned by Marifil, is noted as one of the largest cobalt properties in Argentina. Other noteworthy properties in the company’s portfolio include the Toruel copper-silver property, with more than two contiguous claims, and additional potash properties in Punta Colorada, Pedernal and El Carmen.

Marifil’s sizable portfolio of cobalt and lithium claims in what is recognized as the world’s most prolific mining jurisdiction for these resources strategically positions the company to benefit as global initiatives push demand for lithium-ion batteries toward a frenzy. Zion Market Research, a leading research and consulting firm, has forecast that the lithium-ion battery market could hit $67 billion by 2022, realizing a CAGR of more than 13.7% from 2017-2022. Both lithium and cobalt are major components of these energy storage solutions, with industry data indicating that the battery industry currently consumes roughly 42 percent of global cobalt production.

The company is reviving a lithium exploration program that was active in Argentina a decade ago, building on an unexplored mine it owns there. Marifil will utilize a large proprietary geologic and geochemical data base it developed during its 2009 lithium exploration program in the Salta and Catamarca province sites to resume lithium exploration in the region.

Applications for a second mine and negotiations to purchase a third property are underway, which would establish a significant property portfolio of ‘salar’ brine evaporation lakes. Hydrothermal solutions emanating from regional faults in area volcanoes often enrich the brine with lithium, boron, potassium and magnesium.

In addition to nearly 152,000 acres of lithium-staked properties, Marifil owns 887 acres of land for cobalt exploration and 91,565 acres of gold mining rights in an advanced exploration stage in San Roque that company engineers indicate has high gold discovery potential with “excellent infrastructure and mining friendly politics.”

To date, more than $7.5 million has been invested assessing Marifil’s flagship San Roque gold property, including nearly 16,000 meters of diamond core drilling. The property is jointly owned by Marifil and Novagold Resources, with Marifil holding a 51% stake and serving as the current project operator. The company recently commenced a drilling campaign to further evaluate several deposits of significant gold-silver-indium-lead-zinc mineralization on a 4-kilometer-long zone.

Marifil has closed a private placement funding for $2 million that will inject additional life into the company. Proceeds from the funding will benefit acquisition plans, the ongoing drilling program at Marifil’s gold claim and other output from its general working capital accounts.

Robert Abenante, a chartered professional account, serves as president and chief executive officer of the company. He has extensive experience in the public markets and has served as an officer and director of several public and private companies across various industries, with particular success in the mining sector.

Marifil Mines Ltd. (MFMLF), closed the day's trading session at $0.098, off by 8.41%, on 37,800 volume. The average volume for the last 60 days is 16,221 and the stock's 52-week low/high is $0.0099/$0.165.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.